Vena cava superior syndrome developing in a dialysis patient with antithrombin III deficiency following temporary catheterization

Ünver, Suat; Atasoyu, Enes Murat; Evrenkaya, T. Rıfkı; Özmen, Namık; Arslan, Yucesin; Karaman, Bülent

doi:10.5414/cnp65071

Cited by 3 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Not many data on VCS syndrome post-central venous catheter are available. Previous case reports describe either development of acute VCS syndrome during presence of a catheter [ 15 , 16 ] or short after its removal (2006 [ 17 ]: VCS syndrome 2 weeks after catheter extraction). To the best of our knowledge, this is the first case report describing occurrence of VCS syndrome several years after catheter removal.…”

Section: Discussion/conclusionmentioning

confidence: 99%

Vena Cava Superior Syndrome Six Years after Central Venous Catheter Removal in a Patient on Hemodialysis

Janssen

Logtenberg

2022

Case Rep Nephrol Dial

View full text Add to dashboard Cite

Vena cava superior (VCS) syndrome is rarely seen as a complication of central-venous-catheter placement. Usually, the syndrome appears when the presence of the catheter causes intraluminal obstruction or thrombosis. In this case report, however, we describe a patient on intermittent hemodialysis who had been free of any venous central line for over 6 years, presented with a VCS syndrome. The CT scan showed an absent VCS without extravascular compression. Previous catheter placement was diagnosed as the case of the VCS syndrome. It is important to realize that VCS syndrome can occur late after removal of central venous catheters, and thus, clinicians should be aware of its symptoms in any patient who has had an upper central line in the past medical history.

show abstract

Section: Discussion/conclusionmentioning

confidence: 99%

Vena Cava Superior Syndrome Six Years after Central Venous Catheter Removal in a Patient on Hemodialysis

Janssen

Logtenberg

2022

Case Rep Nephrol Dial

View full text Add to dashboard Cite

show abstract

Superior vena cava obstruction presenting as a complication of repeated central venous cannulations

et al. 2006

View full text Add to dashboard Cite

show abstract

Massive Thrombosis of Brachiocephalic Veins and Superior Vena Cava Syndrome in a Patient with Non-Small Cell Lung Cancer Treated with the Epidermal Growth Factor Receptor Inhibitor Erlotinib

Salmi

Gaudenzi

Todaro

et al. 2007

Clinical Drug Investigation

View full text Add to dashboard Cite

The superior vena cava (SVC) syndrome occurs when obstruction of this vessel interrupts venous return of blood from the head, upper extremities and thorax to the right atrium. Most cases of SVC syndrome result from neoplasia, especially from lung cancer, but other non-cancer-associated causes may include fibrosis caused by radiotherapy, collagen-vascular diseases, arteriovenous shunts or thrombosis as a complication of use of central venous catheters or devices. We report here the case of a 60-year-old woman with non-small cell lung cancer who was treated, after three lines of chemotherapy, with the epidermal growth factor receptor inhibitor erlotinib and subsequently presented to the hospital with abrupt onset of syncope, shortness of breath and cyanosis (face, neck and trunk). A CT scan of the chest demonstrated a massive thrombosis of both brachiocephalic veins and the SVC. The patient was treated with the systemic thrombolytic agent urokinase, with resolution of the clinical picture and no bleeding complications. The possible pathogenetic causes of thrombosis of the brachiocephalic veins and SVC syndrome in this case are discussed. It is possible that acute thrombosis may be associated with erlotinib use, even if it is likely that cancer may be the main cause of the thrombotic complication.

show abstract

Vena cava superior syndrome developing in a dialysis patient with antithrombin III deficiency following temporary catheterization

Cited by 3 publications

References 0 publications

Vena Cava Superior Syndrome Six Years after Central Venous Catheter Removal in a Patient on Hemodialysis

Vena Cava Superior Syndrome Six Years after Central Venous Catheter Removal in a Patient on Hemodialysis

Superior vena cava obstruction presenting as a complication of repeated central venous cannulations

Massive Thrombosis of Brachiocephalic Veins and Superior Vena Cava Syndrome in a Patient with Non-Small Cell Lung Cancer Treated with the Epidermal Growth Factor Receptor Inhibitor Erlotinib

Contact Info

Product

Resources

About